Fundamental Data for LLY

LILLY ELI(NYSE:LLY)

Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

# Employees: 40500

Address: Lilly Corporate Center,Indianapolis,IN,USA

Phone: 317-276-2000

Fax: 317-276-4878

Website: www.lilly.com

Email:

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Sidney Taurel (Chmn.; C.E.O.; Dir.)

John C. Lechleiter Ph.D. (Presi.; C.O.O.; Dir.)

Derica W. Rice (Sr. V.P.; C.F.O.)

Robert A. Armitage (Sr. V.P.; Gen. Consl.)

Martin S. Feldstein Ph.D. (Dir.,)

Dividend

Ex-Dividend Date: 11/10/2009

Annual Dividend: $1.96

Current Dividend Yield: $5.36

Dividend Paid (3 months): $0.49

Indicated Dividend: $0.43

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 1/28/2010

Mean EPS (Next Qtr): $0.93

Mean EPS (Year): $4.43

Mean Estimate(Long Term): $3.50

P/E Ratio(Based on EPS estimate): 8.260

Number of Estimates: 20

Shares Performance

Period	LLY	Compare to S&P
YTD	-9.14 %	-24.80 %
4 Weeks	7.74 %	6.58 %
12 Weeks	8.90 %	2.67 %

Shares Information

Analyst Coverage: Y

Avg Volume: 6640090

Shares Outstanding: 1149M

Market Cap: $42.04B

52 Week High: $40.57

52 Week Low: $27.47

P/E Ratio: 7.970

PEG Ratio: 2.360

Split: On 10/16/1997 LLY split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: 7.14 %

EPS Growth in Last Year: 15.38 %

Sales Growth in Last Quarter: 5.09 %

Sales Growth in Last Quarter: 6.77 %

Financials

Qtr Book Value: $4.24

Cash Flow/Share: $7.53

Change in Payout Ratio: -0.070

Price/Sales: 1.990